על אודות פודקאסט זה 🔗
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
מנחים:
תדירות עדכון:
every 40 days
אורך אודיו ממוצע:
43 minutes
ראיונות אורחים
יש ספונסרים
פודקאסט וידאו
אנגלית
ארצות הברית
107 פרקים
מאז 16 בדצמבר 2017
episodic
בפודקסט זה 🔗
הפרק החדש ביותר 🔗
In this episode of The Onco’Zine Brief Peter Hofland talks with Stephen Spellman. Stephen Spellman is Vice President and Senior Scientific Director at Be The Match and the Center for International Blood & Marrow Transplant Research (CIBMTR). Hofland and Spellman talk about the outcomes of a st…
פרקים קודמים 🔗
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Ely Benaim, MD, the Chief Medical Officer and Executive Vice President Development at SonALAsense and Mark De Souza, Ph.D, President and Chief Executive Officer of SonALAsense.SonALAsense was founded to create hope in the face of de…
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Jeffery Auletta, MD is Senior Vice President, Patient Outcomes and Experience, National Marrow Donor Program® (NMDP)/Be The Match®.Be The Match® is a global leader in bone marrow transplantation. The organization conducts research t…
In a new episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia.Hofland and Cognetti talk about head and neck cancer and a novel treatment approach called …
In this episode of The Onco'Zine Brief, Peter Hofland talks with two experts about their research and the impact the outcomes from these studies may have on the treatment of patients diagnosed with cancer.First, Hofland talks with Christopher Heery, MD.Dr Heery is a board-certified medical oncolog…
Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. However, unlike chemotherapy, ADCs are intended to directly target and kill tumor cells while, at the same time sparing normal, healthy cells. Antibody-drug conjugates consis…
In December 2022 the annual meeting of the American Society of Hematology took place in the vibrant city of New Orleans and brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from initial hypothesis to practice-changin…
In the 100th episode of the Onco’Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match. In the program today Hofl…
In this edition of The Onco'Zine Brief, Peter Hofland, Ph.D, talks with Susanna F. Greer, Ph.D. the Chief Scientific Officer of the V Foundation. In her role, Dr. Greer is a visionary ambassador of the V Foundation, who works with the foundation’s Scientific Advisory Committee to steer funding to …
Despite availability of endocrine therapies for advanced or metastatic breast cancer, there remains a critical unmet need for more effective and convenient treatment options that improve both the patient experience and health outcomes.In today’s episode of The Onco’Zine Brief, Peter Hofland, Ph.D.…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Peter Hofland, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,821,555פודקאסטים ופודקאסטים195,372,593לפי אנשים, מקומות או נושאים.
השקעה בידע מניבה את התשואה הטובה ביותר, ולכן אני מאזין לפודקאסטים.
‐ Benjamin "Llamacorn" Franklin
בוצעה טענה לגבי פודקסט זה
This podcast page is claimed and managed by
@hofland
פודקסט זה מחפש...
נותני חסות
אורחים
מארחים שותפים
קידום צולב
מעוניינים? צרו קשר
מפיק הפודקסט הזה
See other מודעות מסווגות
